Azienda sanitaria universitaria Friuli Centrale - ASUFC

Udine 33100

2 studies enrolling now · 7 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Colorectal Neoplasms, Dermatomyositis, Hepatic Encephalopathy, Immune-Mediated Necrotizing Myopathy, Myelofibrosis, Myeloproliferative Neoplasms, Myositis, Non-small Cell Lung Cancer Metastatic, Polymyositis, Post Essential Thrombocythemia Myelofibrosis

Studies at this site

• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• Study of INCA036978 in Participants With Myeloproliferative Neoplasms — Recruiting now
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy — Enrolling by invitation
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer — Running, not enrolling
• Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy — Stopped early